ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 508.00
-10.00 (-1.93%)
May 7, 2026, 3:30 PM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 60.23 billion as of May 7, 2026. Its market cap has decreased by -74.04% in one year.
Market Cap
60.23B
Enterprise Value
n/a
Revenue
59.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
508.00
Market Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 60.23B, an increase of 93.05%. That is a compound annual growth rate of 2.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 61.42B | -13.81% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 168.38B |
| ENCell | 167.88B |
| Amicogen | 125.27B |
| iNtRON Biotechnology | 109.86B |
| Prestige BioPharma | 103.37B |
| IMB Dx | 100.09B |
| Oncocross | 100.01B |
| CG Invites | 93.04B |